The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 190.00
Bid: 185.00
Ask: 195.00
Change: 0.00 (0.00%)
Spread: 10.00 (5.405%)
Open: 190.00
High: 190.00
Low: 190.00
Prev. Close: 190.00
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Business Update

23 Apr 2020 07:00

RNS Number : 5549K
Synectics PLC
23 April 2020
 

 

 

 

 

23 April 2020

 

 

Synectics plc

("Synectics", the "Company" or the "Group")

 

Business Update

Synectics plc (AIM: SNX), a leader in the design, integration and support of advanced security and surveillance systems, provides the following update ahead of its Annual General Meeting ("AGM") to be held later this morning.

Further to the Company's announcement of 23 March 2020, the Board continues to closely monitor the effect of the Coronavirus (COVID-19) pandemic on Synectics' customers, business and employees. Management is making necessary decisions daily to meet the evolving situation and is closely following all national government regulations and guidance wherever the Company operates.

The Company has a solid cash position and measures in place to ensure that it remains financially sound during this period of uncertainty and beyond. The Group's available consolidated net cash balance was £3.3 million as of 20 April 2020, with confirmed facilities of £5.0 million in place if required.

The Board has taken mitigating actions to preserve the Group's cash and protect the business, including:

· Reducing temporarily salaries and fees for the Board and senior management team across the Group;

· Utilising the UK Government's Job Retention Scheme in order to protect jobs, with 30% of the Company's UK workforce having been furloughed in two tranches during April;

· Applying for support, as appropriate, from government schemes in the US, Germany and Singapore designed to protect jobs; and

· Suspending all discretionary spending, recruitment and capital expenditure in addition to withdrawing the resolution to recommend payment of the final dividend at the AGM.

Business Operations

All the Company's business units are currently operating, but at significantly reduced levels of activity in every sector and geography. Reasonable levels of design and planning work are continuing for projects now expected to proceed later in the year than originally anticipated.

We continue to provide essential service and support to our customers on-site where required and have increased our remote support capabilities. The Company's business is to provide security and safety systems; employees and customers are well aware of the role they play in protecting communities around the world and we are making every effort to ensure that customers can continue to rely on us at this difficult time.

Planned investment in software development continues, with only limited impact as a result of COVID-19.

People

With most staff working from home and others furloughed, we have instigated a specific programme to keep colleagues connected to the business and each other. The Group is making extensive use of video conferencing and other communication tools to facilitate continued effective teamwork and to minimise any potential sense of isolation.

Outlook

Synectics' priorities continue to be:

· to protect the health and well-being of its employees and customers;

· to provide ongoing support to its customers, especially where we are providing essential security and safety; and

· to manage the business for the long term by prudent actions to preserve cash and maintain capability.

As announced on 23 March 2020, and given the continued uncertainty in global markets, financial guidance on the Company's expected trading performance for the financial year ending 30 November 2020 has been and remains suspended.

Regular updates are provided on the Company's website and further announcements will be made as appropriate.

David Coghlan, Chairman of Synectics, commented:

 "Synectics is a global business with a solid balance sheet, and we have taken immediate measures to contain costs and protect our financial position.

"The Company fills a number of important roles in the wider security and surveillance industry. The Board is determined that Synectics will maintain its skills, resources and product development momentum and, by doing so, be well-placed for new opportunities that will undoubtedly emerge as we reach the other side of the current hiatus."

For further information, please contact:

Synectics plc

Tel: +44 (0) 114 280 2828

Paul Webb, Chief Executive

David Coghlan, Chairman

 

email: info@synecticsplc.com

www.synecticsplc.com

 

 

Shore Capital

Tel: +44 (0) 20 7408 4050

Tom Griffiths / Henry Willcocks

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDEASLAADPEEFA
Date   Source Headline
20th Apr 202212:05 pmRNSResult of AGM
20th Apr 20227:00 amRNSAGM Statement
4th Apr 202210:47 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSPosting of Accounts and Notice of AGM
8th Mar 20227:00 amRNSLong Term Infrastructure Contract
4th Mar 20227:00 amRNSAvailability of Annual Report and Accounts
22nd Feb 20227:00 amRNSFinal Results
16th Feb 20227:36 amRNSInvestor Presentation
2nd Feb 20227:00 amRNSNotification of Final Results
14th Dec 20217:00 amRNSContract for New Buses in Northern Ireland
8th Dec 20217:00 amRNSTrading Update
3rd Nov 20217:00 amRNSNew Casino Projects in North America
28th Oct 20217:00 amRNSMajor Project for West Midlands Police
1st Oct 20212:15 pmRNSDirector/PDMR Shareholding
23rd Aug 20217:00 amRNSContract Award for New Refinery Project
13th Jul 20217:00 amRNSHalf-year Report
14th Jun 20217:00 amRNSTrading Update
2nd Jun 20217:00 amRNSDirector/PDMR Shareholding
28th May 20217:00 amRNSDirector/PDMR Shareholding
11th May 20217:00 amRNSHolding(s) in Company
27th Apr 202111:22 amRNSResult of AGM
27th Apr 20217:00 amRNSBusiness Update
23rd Apr 20214:23 pmRNSHolding(s) in Company
7th Apr 20211:08 pmRNSDirector/PDMR Shareholding
7th Apr 20217:00 amRNSSynectics secures major City of London project
31st Mar 20217:00 amRNSHolding(s) in Company
23rd Mar 20217:00 amRNSPosting of Accounts and Notice of AGM
17th Mar 20217:00 amRNSDirector’s/PCA’s Interest in Shares
4th Mar 20217:00 amRNSPDMR’s Interest in Shares
2nd Mar 20217:00 amRNSFinal Results
17th Feb 20217:00 amRNSFurther contract wins in Irish bus market
10th Feb 20217:00 amRNSLetter of Intent and Notification of Results Date
7th Jan 20217:00 amRNSSynectics’ S-Bahn project goes live
15th Dec 20207:00 amRNSTrading Update
1st Dec 20207:00 amRNSSynectics appoints Dr Kerstin Wendt
26th Nov 20207:00 amRNSDirector/PDMR Shareholding
19th Nov 20207:36 amRNSDirector/PDMR Shareholding
18th Nov 202011:53 amRNSDirector/PDMR Shareholding
17th Nov 20207:00 amRNSContract Win
2nd Oct 202011:02 amRNSDirector/PDMR dealings
29th Sep 20207:00 amRNSTrading Update
12th Aug 20207:00 amRNSDirector/PDMR Shareholding
10th Aug 20207:00 amRNSDirectors' / PDMRs' Interests in Shares
30th Jul 20202:03 pmRNSDirector/PDMR Shareholding
28th Jul 20207:00 amRNSDirector/PDMR Shareholding
28th Jul 20207:00 amRNSContract Wins for 'next generation' Irish Buses
27th Jul 20204:40 pmRNSSecond Price Monitoring Extn
27th Jul 20204:35 pmRNSPrice Monitoring Extension
27th Jul 20207:00 amRNSHolding(s) in Company
23rd Jul 20208:22 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.